2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))

C136H84N20O4Pt4 — CID 159318209

About 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))

2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)) (PubChem CID 159318209) has the molecular formula C136H84N20O4Pt4 and a molecular weight of 2842.62 g/mol. Its IUPAC name is 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)).

Molecular Properties

• Compound Name: 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))
• PubChem CID: 159318209
• Molecular Formula: C136H84N20O4Pt4
• Molecular Weight: 2842.62 g/mol
• Exact Mass: 2840.56
• IUPAC Name: 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))
• SMILES: Cn1c(-c2[c-]c3c(c(-c4ncco4)c2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccc(-c3ncco3)cc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2cccc(-c3ncco3)c21.Cn1c(-c2[c-]c3c(cc2-c2ncco2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/4C34H21N5O.4Pt/c1-38-30-15-5-3-13-28(30)37-33(38)23-20-26(34-36-17-18-40-34)32-25-11-2-4-14-29(25)39(31(32)21-23)24-10-8-9-22(19-24)27-12-6-7-16-35-27;1-38-31-15-5-3-13-29(31)37-33(38)26-21-32-25(20-27(26)34-36-17-18-40-34)24-11-2-4-14-30(24)39(32)23-10-8-9-22(19-23)28-12-6-7-16-35-28;1-38-32-27(34-36-18-19-40-34)11-7-13-29(32)37-33(38)23-15-16-26-25-10-2-3-14-30(25)39(31(26)21-23)24-9-6-8-22(20-24)28-12-4-5-17-35-28;1-38-32-21-24(34-36-17-18-40-34)13-15-29(32)37-33(38)23-12-14-27-26-9-2-3-11-30(26)39(31(27)20-23)25-8-6-7-22(19-25)28-10-4-5-16-35-28;;;;/h2*2-18,20H,1H3;2-19H,1H3;2-18,21H,1H3;;;;/q4*-2;4*+2
• InChIKey: PKYJZCCYZAJRAQ-UHFFFAOYSA-N
• XLogP: 30.61
• TPSA: 246.68 Ų
• H-Bond Acceptors: 24
• Rotatable Bonds: 16
• Heavy Atoms: 164
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2842.62
LogP ≤ 5	30.61
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	24

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))?

The IUPAC name of 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)) (CID 159318209) is 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)).

What is the SMILES notation for 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))?

The canonical SMILES for 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)) is Cn1c(-c2[c-]c3c(c(-c4ncco4)c2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccc(-c3ncco3)cc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2cccc(-c3ncco3)c21.Cn1c(-c2[c-]c3c(cc2-c2ncco2)c2ccccc2n3-c2[c-]c(-c3ccccn3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))?

The InChIKey is PKYJZCCYZAJRAQ-UHFFFAOYSA-N. The full InChI is InChI=1S/4C34H21N5O.4Pt/c1-38-30-15-5-3-13-28(30)37-33(38)23-20-26(34-36-17-18-40-34)32-25-11-2-4-14-29(25)39(31(32)21-23)24-10-8-9-22(19-24)27-12-6-7-16-35-27;1-38-31-15-5-3-13-29(31)37-33(38)26-21-32-25(20-27(26)34-36-17-18-40-34)24-11-2-4-14-30(24)39(32)23-10-8-9-22(19-23)28-12-6-7-16-35-28;1-38-32-27(34-36-18-19-40-34)11-7-13-29(32)37-33(38)23-15-16-26-25-10-2-3-14-30(25)39(31(26)21-23)24-9-6-8-22(20-24)28-12-4-5-17-35-28;1-38-32-21-24(34-36-17-18-40-34)13-15-29(32)37-33(38)23-12-14-27-26-9-2-3-11-30(26)39(31(27)20-23)25-8-6-7-22(19-25)28-10-4-5-16-35-28;;;;/h2*2-18,20H,1H3;2-19H,1H3;2-18,21H,1H3;;;;/q4*-2;4*+2.

What are the key properties of 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+))?

2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)) has a molecular weight of 2842.62 g/mol, XLogP of 30.61, 16 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-3-yl]-1,3-oxazole;2-[2-(1-methylbenzimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-4-yl]-1,3-oxazole;2-[3-methyl-2-[9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]benzimidazol-5-yl]-1,3-oxazole;tetrakis(platinum(2+)) is sourced from PubChem (CID 159318209), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).